S. C. Fagan

1.5k total citations
18 papers, 907 citations indexed

About

S. C. Fagan is a scholar working on Epidemiology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S. C. Fagan has authored 18 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Neurology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S. C. Fagan's work include Acute Ischemic Stroke Management (7 papers), Advanced MRI Techniques and Applications (4 papers) and Neurological Disease Mechanisms and Treatments (2 papers). S. C. Fagan is often cited by papers focused on Acute Ischemic Stroke Management (7 papers), Advanced MRI Techniques and Applications (4 papers) and Neurological Disease Mechanisms and Treatments (2 papers). S. C. Fagan collaborates with scholars based in United States and Canada. S. C. Fagan's co-authors include John R. Marler, R G Hart, Collin A. Hovinga, Declan Murphy, Ted M. Dawson, Bernard Ravina, Gilmore O’Neill, Lucie Bruijn, Bryan J. Traynor and Robin Conwit and has published in prestigious journals such as Neurology, Stroke and Annals of Neurology.

In The Last Decade

S. C. Fagan

17 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. C. Fagan United States	10	349	333	173	145	141	18	907
Yasuhisa Kitagawa Japan	19	443 1.3×	295 0.9×	158 0.9×	311 2.1×	124 0.9×	70	1.3k
Nina J. Solenski United States	16	578 1.7×	222 0.7×	152 0.9×	116 0.8×	281 2.0×	39	1.2k
E. Bottacchi Italy	21	902 2.6×	327 1.0×	233 1.3×	56 0.4×	256 1.8×	49	1.5k
Mark Willmot United Kingdom	11	459 1.3×	569 1.7×	78 0.5×	232 1.6×	146 1.0×	14	1.2k
Barbara Casolla France	18	340 1.0×	445 1.3×	60 0.3×	92 0.6×	118 0.8×	64	1.0k
Agnieszka Słowik Poland	21	441 1.3×	388 1.2×	68 0.4×	117 0.8×	199 1.4×	90	1.3k
C. Gómez–Escalonilla Spain	17	288 0.8×	185 0.6×	98 0.6×	35 0.2×	185 1.3×	38	778
Jonathan Rhodes United Kingdom	18	719 2.1×	355 1.1×	88 0.5×	48 0.3×	210 1.5×	33	1.3k
Kotaro Miyashita Japan	18	163 0.5×	172 0.5×	109 0.6×	162 1.1×	174 1.2×	76	1.0k

Countries citing papers authored by S. C. Fagan

Since Specialization

Citations

This map shows the geographic impact of S. C. Fagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. C. Fagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. C. Fagan more than expected).

Fields of papers citing papers by S. C. Fagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. C. Fagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. C. Fagan. The network helps show where S. C. Fagan may publish in the future.

Co-authorship network of co-authors of S. C. Fagan

This figure shows the co-authorship network connecting the top 25 collaborators of S. C. Fagan. A scholar is included among the top collaborators of S. C. Fagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. C. Fagan. S. C. Fagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bushnell, Cheryl, DaiWai M. Olson, Xin Zhao, et al.. (2011). Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 77(12). 1182–1190. 195 indexed citations

Traynor, Bryan J., Lucie Bruijn, Robin Conwit, et al.. (2006). Neuroprotective agents for clinical trials in ALS. Neurology. 67(1). 20–27. 161 indexed citations

Ravina, Bernard, S. C. Fagan, R G Hart, et al.. (2003). Neuroprotective agents for clinical trials in Parkinson’s disease. Neurology. 60(8). 1234–1240. 218 indexed citations

Broderick, Joseph, Mei Lü, Christy Jackson, et al.. (2001). Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Annals of Neurology. 49(6). 736–744. 39 indexed citations

Frighetto, Luciana, Peter Loewen, Rubina Sunderji, et al.. (2001). Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke. PharmacoEconomics. 19(9). 927–936. 56 indexed citations

Riggs, Jack E., Zurab Nadareishvili, Pyung Chun Oh, et al.. (1999). Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke [2] (multiple letters). 52(4). 895–896. 3 indexed citations

Brown, Gregory G., et al.. (1998). Neuropsychological Dose Effects of a Freon, Trifluoromethane (FC-23), Compared to N2O. Neurotoxicology and Teratology. 20(6). 617–626. 1 indexed citations

Fagan, S. C., et al.. (1998). MGB4 Relationship Between Quality of Life, Disease Severity, And Physician Visits in Managed Care Patients with Atopic Dermatitis. Value in Health. 1(1). 45–46. 1 indexed citations

Knight, Robert A., Peter B. Barker, S. C. Fagan, et al.. (1998). Prediction of Impending Hemorrhagic Transformation in Ischemic Stroke Using Magnetic Resonance Imaging in Rats. Stroke. 29(1). 144–151. 95 indexed citations

10.

Gidal, Barry E., M. Lynn Crismon, Mary Wagner, et al.. (1996). Current Developments in Neurology, Part II: Advances in the Pharmacotherapy of Alzheimer Disease, Parkinson's Disease, and Stroke. Annals of Pharmacotherapy. 30(12). 1446–1451. 4 indexed citations

11.

Bowes, Mark P., Justin A. Zivin, George Thomas, Harold Thibodeaux, & S. C. Fagan. (1996). Acute Hypertension, but Not Thrombolysis, Increases the Incidence and Severity of Hemorrhagic Transformation Following Experimental Stroke in Rabbits. Experimental Neurology. 141(1). 40–46. 59 indexed citations

12.

Fagan, S. C., Heather Kertland, & Gretchen E. Tietjen. (1994). Safety of Combination Aspirin and Anticoagulation in Acute Ischemic Stroke. Annals of Pharmacotherapy. 28(4). 441–443. 1 indexed citations

13.

Fagan, S. C., James R. Ewing, Steve Levine, et al.. (1991). Assessing the Effects of Antihypertensive Medication on Cerebral Blood Flow: Demonstration in Internal Carotid Artery Occlusion. DICP. 25(12). 1299–1301. 4 indexed citations

14.

Ewing, James R., et al.. (1990). Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonance.. Stroke. 21(1). 100–106. 18 indexed citations

15.

Branch, C A, James R. Ewing, S. C. Fagan, David A. Goldberg, & K.M.A. Welch. (1990). Acute toxicity of a nuclear magnetic resonance cerebral blood flow indicator in cats.. Stroke. 21(8). 1172–1177. 9 indexed citations

16.

Fagan, S. C., et al.. (1988). Effect of nimodipine on blood pressure in acute ischemic stroke in humans.. Stroke. 19(3). 401–402. 23 indexed citations

17.

Fagan, S. C., et al.. (1986). PROSTANOID CONCENTRATIONS IN HUMAN CSF FOLLOWING ACUTE ISCHAEMIC BRAIN INFARCTION. Clinical and Experimental Pharmacology and Physiology. 13(8). 629–632. 12 indexed citations

18.

Gengo, Fran M., S. C. Fagan, William R. Kinkel, & William B. McHugh. (1984). Serum Concentrations of Propranolol and Migraine Prophylaxis. Archives of Neurology. 41(12). 1306–1307. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact